| +0.02 / +0.08%|
Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag and PediMag/PediVAS product lines. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart failure patients. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA.
|Gerhard F. Burbach||President, Chief Executive Officer & Director|
|Taylor C. Harris||Chief Financial Officer & Vice President|
|David A. Lehman||Secretary, Senior Vice President & General Counsel|
|Vasant Padmanabhan||Senior Vice President-Technical Operations|
|Neil R. Meyer||Director-Investor Relations|